Cresco Labs (CRLBF) Goodwill & Intangibles (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Goodwill & Intangibles came in at $497.5 million in Q1 2026, down 13.75% YoY from $576.8 million in Q1 2025, and up 2.89% on a QoQ basis from $483.5 million in Q4 2025.
Cresco Labs (CRLBF) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Goodwill & Intangibles data on file, last reported at $497.5 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 13.75% year-over-year to $497.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $497.5 million (down 13.75% YoY) and the FY2025 annual result came in at $483.5 million, down 16.27% from the prior year.
- Goodwill & Intangibles grew to $497.5 million in Q1 2026, from $483.5 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $884.3 million in Q1 2022 to a low of $483.5 million in Q4 2025.
- A 5-year average of $647.7 million and a median of $577.8 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles soared 31.01% — and 2023, when it sank 34.34%.
- Tracing CRLBF's Goodwill & Intangibles over 5 years: stood at $738.1 million in 2022, then dropped by 21.88% to $576.7 million in 2023, then climbed by 0.14% to $577.5 million in 2024, then dropped by 16.27% to $483.5 million in 2025, then increased by 2.89% to $497.5 million in 2026.
- The last three Goodwill & Intangibles figures came in at $497.5 million (Q1 2026), $483.5 million (Q4 2025), and $575.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 497.49 Mn |
| Dec 31, 2025 | 483.52 Mn |
| Sep 30, 2025 | 575.48 Mn |
| Jun 30, 2025 | 572.75 Mn |
| Mar 31, 2025 | 576.80 Mn |
| Dec 31, 2024 | 577.48 Mn |
| Sep 30, 2024 | 579.28 Mn |
| Jun 30, 2024 | 583.33 Mn |
| Mar 31, 2024 | 577.77 Mn |
| Dec 31, 2023 | 576.66 Mn |
| Sep 30, 2023 | 577.71 Mn |
| Jun 30, 2023 | 712.85 Mn |
| Mar 31, 2023 | 736.65 Mn |
| Dec 31, 2022 | 738.15 Mn |
| Sep 30, 2022 | 879.82 Mn |
| Jun 30, 2022 | 881.72 Mn |
| Mar 31, 2022 | 884.27 Mn |
| Dec 31, 2021 | 884.41 Mn |
| Mar 31, 2021 | 674.95 Mn |
| Dec 31, 2020 | 289.57 Mn |